GLP-1-based therapies offer a pharmacological intervention that targets these mechanisms directly, allowing for more effective management of obesity
efficiency, liposome formulation demonstrated 7.2% loading efficacy, 120 nm vesicle size, and 16.2mV zeta potential
The platform integrates over 500 million patents, scientific publications, clinical trial records, and market intelligence sources through a proprietary R&D ontology purpose-built for technology scouting and competitive analysis
Cheung, A., Podgorny, P., Martinez, J
Even a modest weight loss of 5% has been shown to improve cardiometabolic risk factors, including reduced systolic blood pressure and plasma triglyceride concentration, and increased multi-organ insulin sensitivity and -cell function [6]
The higher dose of 0.14 mol/kg had even greater effects, with less than 25% of radioactivity remaining in the stomach after 15 minutes